← Eichor
Condition: Consolidation Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Consolidation Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06232694Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
Phase 2 · 1 location(s) · Daihong Liu · NCT07321301Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03128879BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Phase 2 · 33 location(s) · SCRI Development Innovations, LLC · NCT06773910ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06426511Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens
Phase 2/Phase 3 · 56 location(s) · University Hospital, Angers · NCT02416388tDCS: Sleep to Mood in Depression (S2M-D)
NA · 1 location(s) · NYU Langone Health · NCT07572526Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Do
Phase 1 · 5 location(s) · Celyad Oncology SA · NCT04167696IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
Phase 2 · 1 location(s) · Dickran Kazandjian, MD · NCT06376526Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07177794FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer,
Phase 2 · 6 location(s) · Northwestern University · NCT06244004CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma
Phase 2 · 1 location(s) · Liping Dou · NCT07587840Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT06022939Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Pat
Phase 3 · 43 location(s) · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT07223814A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage
Phase 2 · 2 location(s) · Henan Cancer Hospital · NCT07559786Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treat
Phase 2 · 14 location(s) · Delcath Systems Inc. · NCT06607458Sleep and Motor Learning in Stroke
Phase N/A · 1 location(s) · University of Oxford · NCT05746260Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Inte
Phase 3 · 1 location(s) · Yehui Tan · NCT06990321Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
Phase 2 · 5 location(s) · University Hospital, Bonn · NCT06810609Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherap
Phase 2 · 6 location(s) · University of Kansas Medical Center · NCT04992780Disrupting Fear-based Memory Consolidation
NA · 2 location(s) · Emory University · NCT05560113Durvalumab as Consolidation for Patients LS-SCLC
Phase 2 · 2 location(s) · Qian Chu · NCT07055581A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLB
Phase 2 · 1 location(s) · Danielle Wallace · NCT06828991Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-
Phase 3 · 91 location(s) · University of Ulm · NCT04628026Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
Phase 2/Phase 3 · 1 location(s) · Hospital Regional de Alta Especialidad del Bajio · NCT05595447Human Learning of New Structured Information Across Time and Sleep
NA · 1 location(s) · University of Pennsylvania · NCT05910762Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
Phase 2 · 2 location(s) · Rutgers, The State University of New Jersey · NCT05366829
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.